Back to ABT

ABBOTT LABORATORIES Non-operating Income/Expense 2007-2026 | ABT

Beta

What is ABBOTT LABORATORIES's current non-operating income/expense?

ABBOTT LABORATORIES (ABT) annual non-operating income/expense for 2025 was $548.0M, a 45.74% increase from 2024. ABBOTT LABORATORIES non-operating income/expense for the quarter ending March 31, 2026 was $159.0M.

What was ABBOTT LABORATORIES's non-operating income/expense in 2024?

ABBOTT LABORATORIES annual non-operating income/expense for 2024 was $376.0M, a 21.50% decline from 2023.

What was ABBOTT LABORATORIES's non-operating income/expense in 2023?

ABBOTT LABORATORIES annual non-operating income/expense for 2023 was $479.0M, a 49.22% increase from 2022.

What is ABBOTT LABORATORIES's 5-year non-operating income/expense CAGR?

ABBOTT LABORATORIES non-operating income/expense grew at a compound annual growth rate (CAGR) of 39.70% from FY2020 to FY2025, going from $103.0M to $548.0M over 5 years.

Non-operating Income/Expense History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR+39.7%
FY2020
$103.0M
FY2025
$548.0M
07080910111213141516171819202122232425
5 years selected
Non-operating Income/Expense History
PeriodValueChangeSource
FY2025$548.0M+45.7%10-K
FY2024$376.0M-21.5%10-K
FY2023$479.0M+49.2%10-K
FY2022$321.0M+15.9%10-K
FY2021$277.0M+168.9%10-K
FY2020$103.0M-46.1%10-K
FY2019$191.0M+37.4%10-K
FY2018$139.0M-90.2%10-K
FY2017$1.41B+279.8%10-K
FY2016$-786.0M-379.7%10-K
FY2015$281.0M+2107.1%10-K
FY2014$-14.0M-143.8%10-K
FY2013$32.0M+3100.0%10-K
FY2012$1.0M+100.8%10-K
FY2011$-119.0M-291.9%10-K
FY2010$62.0M-95.5%10-K
FY2009$1.38B+202.3%10-K
FY2008$454.9M+435.7%10-K
FY2007$-135.5M-10-K
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →